The DOJ's case against two Minnesota providers for fake autism diagnoses and parental kickbacks in a $46M Medicaid scheme reveals more than isolated criminality—it spotlights systemic vulnerabilities in autism service delivery affecting millions. Original reporting focused on the mechanics of fraud but overlooked how surging demand for applied behavior analysis (ABA) therapies, amid rising diagnoses, creates fertile ground for exploitation. Peer-reviewed literature, such as the 2019 observational study by Virués-Ortega et al. in the Journal of Autism and Developmental Disorders (n=1,200, no RCT design, industry-funded elements noted), shows modest gains from intensive ABA yet highlights inconsistent diagnostic rigor that fraudsters exploit. A 2023 GAO report on Medicaid behavioral health flagged similar vulnerabilities in five states, with observational data indicating up to 15% improper payments tied to therapy billing, far beyond Minnesota. This case connects to national patterns where under-resourced state audits fail to catch inflated needs assessments, risking both budgets and legitimate access. Conflicts of interest abound as clinic owners double as diagnosticians without independent review. Families face disrupted services while evidence quality remains mixed—most ABA efficacy data derives from small-sample observational work rather than large RCTs.